Detalhe da pesquisa
1.
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.
Lancet
; 403(10436): 1563-1573, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554726
2.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Lancet
; 403(10432): 1153-1163, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461843
3.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Lancet
; 402(10411): 1449-1458, 2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696275
4.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Lancet
; 402(10411): 1434-1448, 2023 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865470
5.
Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study.
Ophthalmology
; 131(1): 66-77, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661066
6.
Treatment of geographic atrophy: an update on data related to pegcetacoplan.
Curr Opin Ophthalmol
; 35(1): 64-72, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815317
7.
Topographic analysis of local OCT biomarkers which predict progression to atrophy in age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300334
8.
Suprachoroidal Space Injection Technique: Expert Panel Guidance.
Retina
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451179
9.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet
; 399(10326): 741-755, 2022 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085503
10.
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 130(6): 588-597, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754174
11.
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry.
Ophthalmology
; 130(9): 937-946, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086857
12.
Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.
Ophthalmology
; 130(8): 795-803, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990322
13.
Patient-Reported Outcome Measure Use in Guidelines Published by the American Academy of Ophthalmology: A Review.
Ophthalmology
; 130(11): 1201-1211, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429499
14.
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Ophthalmology
; 130(7): 735-747, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870451
15.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Ophthalmology
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158159
16.
INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PHARMACEUTICAL UTILIZATION AND FINANCIAL IMPACT IN A VALUE-BASED CARE PROGRAM.
Retina
; 43(3): 506-513, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730588
17.
USE OF OPTICAL COHERENCE TOMOGRAPHY IN DETECTING RETINAL TEARS IN ACUTE, SYMPTOMATIC POSTERIOR VITREOUS DETACHMENT.
Retina
; 43(5): 802-807, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728866
18.
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence.
Retina
; 43(7): 1051-1063, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893438
19.
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid.
Ophthalmology
; 129(9): 974-985, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537533
20.
The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis.
Ophthalmology
; 129(5): 498-508, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871637